Manulife Offloads $3.2 Billion in Long-Term Care Risk to Munich Re — Manulife Financial Corporation

Event summary

$3.2 billion long-term care (LTC) reinsurance deal with Munich Re Life US, expected to close Q4 2026.
Third LTC reinsurance transaction in under three years; first on a standalone block.
Cumulative reduction of LTC morbidity sensitivity by 24% post-closing.
Transaction neutral to capital, with ~$30 million annual impact on core earnings, reducing over time.

The big picture

Manulife's latest move underscores a broader industry trend of insurers shedding long-term care risk to improve capital efficiency. The $3.2 billion transaction with Munich Re follows similar deals with Global Atlantic and RGA, reflecting a strategic shift toward reducing exposure to LTC morbidity sensitivity. This deal highlights Manulife's ability to structure innovative reinsurance transactions, but it also raises questions about the sustainability of such large-scale risk transfers.

What we're watching

Risk Reduction Strategy: Whether Manulife can sustain its aggressive LTC risk offloading pace without disrupting core operations.
Capital Efficiency: How the transaction's modest negative 5% cede will affect long-term capital allocation and shareholder returns.
Regulatory Approval: The pace at which regulatory approvals are secured, given the deal's size and complexity.